Scientists Create Most Sophisticated Human Liver Model Yet
News Feb 14, 2018 | Original story from Wake Forest Baptist Medical Center
Scientists at Wake Forest Institute for Regenerative Medicine (WFIRM) have developed the most sophisticated mini-livers to date. These organoids can potentially help scientists better understand certain congenital liver diseases as well as speed up efforts to create liver tissue in the lab for transplantation into patients.
“This model better mimics fetal development and function of the human liver,” said Shay Soker, Ph.D., professor of regenerative medicine at WFIRM, which is part of Wake Forest Baptist Medical Center. “We expect these organoids to advance our understanding of how liver diseases – especially congenital diseases -- start and progress so improved treatments can be developed.”
Soker was lead researcher on the study, which is reported in Hepatology.
The creation of living mini-organs is a relatively new area of science with the potential to replace animal models that are not always accurate. The liver organoids, made with human cells, are less than one-third inch in diameter. While scientists have already created liver organoids to screen new drugs for liver toxicity, the livers developed in this research represent several “firsts” in the quest to build a functional model of human liver development.
To make the organoids, scientists allow fetal liver progenitor cells, an immature cell that is destined to become a specialized liver cell, to self-assemble on a small disc. The discs are made of ferret liver that has been processed to remove all of the animal’s cells. The resulting organoids, which assemble within two to three weeks, are the first to model actual human liver development.
The research is significant in two ways. First, the scientists showed that these organoids generated hepatocytes, the main functional cells of the liver. This achievement represents a milestone in work to create truly functional bioengineered liver tissue for transplantation into patients.
Second, while other scientists have shown that lab-grown livers can generate bile ducts, this is the first study to show the stepwise maturation of bile ducts exactly as can be observed in the human fetal liver. Bile ducts carry bile, a fluid that is secreted by the liver and collected in the gall bladder to digest fats. This model of bile ductal development can potentially be used to study the hereditary disease biliary atresia that occurs in infants. With this disease, bile drainage is impaired, making it fatal in the more severe cases.
“Altogether, the team has created a laboratory model of human liver development and disease that will help advance our understanding about bile duct formation,” said first co-author Pedro Baptista, Pharm.D., Ph.D., who was with WFIRM at the time of the research.
“This is a big step toward advancing the bioengineering of functional livers and bile ducts and we look forward to using it in a variety of ways to mprove human health,” said first co-author Dipen Vyas, Ph.D., also at WFIRM at the time of the research.
This article has been republished from materials provided by Wake Forest Baptist Medical Center. Note: material may have been edited for length and content. For further information, please contact the cited source.
Cryo-EM Reveals Interaction Between Major Drug TargetsNews
For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.READ MORE
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Novel Microplate 3D Bioprinting Platform for Engineering Muscle and Tendon TissuesNews
There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. Researchers describe the development of a novel screening platform with automated production of 3D muscle- and tendon–like tissues using 3D bioprinting.READ MORE